Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-07-26
Original market date: See footnote 1
2023-07-26
Product name:
ACETAZOLAMIDE FOR INJECTION USP
Description:
SINGLE USE VIAL
DIN:
02537893
Product Monograph/Veterinary Labelling:
Date:
2023-05-12
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MARCAN PHARMACEUTICALS INC
2 Gurdwara Rd., Suite 112
Ottawa
Ontario
Canada
K2E 1A2
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:40.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01EC01 ACETAZOLAMIDE
Active ingredient group (AIG) number:See footnote5
0107512002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ACETAZOLAMIDE (ACETAZOLAMIDE SODIUM) | 500 MG / VIAL |